|
1
|
Cook BE Jr and Bartley GB: Epidemiologic
characteristics and clinical course of patients with malignant
eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
Ophthalmology. 106:746–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allali J, D'Hermies F and Renard G: Basal
cell carcinomas of the eyelids. Ophthalmologica. 219:57–71. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neale RE, Davis M, Pandeya N, Whiteman DC
and Green AC: Basal cell carcinoma on the trunk is associated with
excessive sun exposure. J Am Acad Dermatol. 56:380–386. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lindgren G, Lindblom B and Larkö O: Mohs'
micrographic surgery for basal cell carcinomas on the eyelids and
medial canthal area. II. Reconstruction and follow-up. Acta
Ophthalmol Scand. 78:430–436. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malhotra R, Huilgol SC, Huynh NT and Selva
D: The Australian Mohs database, part II: Periocular basal cell
carcinoma outcome at 5-year follow-up. Ophthalmology. 111:631–636.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morris DS, Elzaridi E, Clarke L, Dickinson
AJ and Lawrence CM: Periocular basal cell carcinoma: 5-year outcome
following Slow Mohs surgery with formalin-fixed paraffin-embedded
sections and delayed closure. Br J Ophthalmol. 93:474–476. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Margo CE and Waltz K: Basal cell carcinoma
of the eyelid and periocular skin. Surv Ophthalmol. 38:169–192.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diepgen TL and Mahler V: The epidemiology
of skin cancer. Br J Dermatol. 146:1–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Zwaan SE and Haass NK: Genetics of
basal cell carcinoma. Australas J Dermatol. 51:81–92; quiz 93–94.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Muller PA, Vousden KH and Norman JC: p53
and its mutants in tumor cell migration and invasion. J Cell Biol.
192:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heller ER, Gor A, Wang D, Hu Q, Lucchese
A, Kanduc D, Katdare M, Liu S and Sinha AA: Molecular signatures of
basal cell carcinoma susceptibility and pathogenesis: A genomic
approach. Int J Oncol. 42:583–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tabuchi Y, Yunoki T, Hoshi N, Suzuki N and
Kondo T: Genes and gene networks involved in sodium
fluoride-elicited cell death accompanying endoplasmic reticulum
stress in oral epithelial cells. Int J Mol Sci. 15:8959–8978. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yunoki T, Tabuchi Y, Hayashi A and Kondo
T: Network analysis of genes involved in the enhancement of
hyperthermia sensitivity by the knockdown of BAG3 in human oral
squamous cell carcinoma cells. Int J Mol Med. 38:236–242. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reifenberger J, Wolter M, Knobbe CB,
Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka
T and Reifenberger G: Somatic mutations in the PTCH, SMOH, SUFUH
and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol.
152:43–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Palmer CJ, Galan-Caridad JM, Weisberg SP,
Lei L, Esquilin JM, Croft GF, Wainwright B, Canoll P, Owens DM and
Reizis B: Zfx facilitates tumorigenesis caused by activation of the
Hedgehog pathway. Cancer Res. 74:5914–5924. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lupu M, Caruntu C, Ghita MA, Voiculescu V,
Voiculescu S, Rosca AE, Caruntu A, Moraru L, Popa IM, Calenic B, et
al: Gene expression and proteome analysis as sources of biomarkers
in basal cell carcinoma. Dis Markers. 2016:98312372016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Celebi AR, Kiratli H and Soylemezoglu F:
Evaluation of the ‘Hedgehog’ signaling pathways in squamous and
basal cell carcinomas of the eyelids and conjunctiva. Oncol Lett.
12:467–472. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Astarci HM, Gurbuz GA, Sengul D,
Hucumenoglu S, Kocer U and Ustun H: Significance of androgen
receptor and CD10 expression in cutaneous basal cell carcinoma and
trichoepithelioma. Oncol Lett. 10:3466–3470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sharpe HJ, Pau G, Dijkgraaf GJ,
Basset-Seguin N, Modrusan Z, Januario T, Tsui V, Durham AB, Dlugosz
AA, Haverty PM, et al: Genomic analysis of smoothened inhibitor
resistance in basal cell carcinoma. Cancer Cell. 27:327–341. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trautinger F, Kindas-Mügge I, Dekrout B,
Knobler RM and Metze D: Expression of the 27-kDa heat shock protein
in human epidermis and in epidermal neoplasms: An
immunohistological study. Br J Dermatol. 133:194–202. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vidal VP, Ortonne N and Schedl A: SOX9
expression is a general marker of basal cell carcinoma and
adnexal-related neoplasms. J Cutan Pathol. 35:373–379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Youssef KK, Lapouge G, Bouvrée K, Rorive
S, Brohée S, Appelstein O, Larsimont JC, Sukumaran V, Van de Sande
B, Pucci D, et al: Adult interfollicular tumour-initiating cells
are reprogrammed into an embryonic hair follicle progenitor-like
fate during basal cell carcinoma initiation. Nat Cell Biol.
14:1282–1294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zbacnik AP, Rawal A, Lee B, Werling R,
Knapp D and Mesa H: Cutaneous basal cell carcinosarcoma: Case
report and literature review. J Cutan Pathol. 42:903–910. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Regl G, Kasper M, Schnidar H, Eichberger
T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C,
Frischauf AM and Aberger F: Activation of the BCL2 promoter in
response to Hedgehog/GLI signal transduction is predominantly
mediated by GLI2. Cancer Res. 64:7724–7731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He D, Li L, Zhu G, Liang L, Guan Z, Chang
L, Chen Y, Yeh S and Chang C: ASC-J9 suppresses renal cell
carcinoma progression by targeting an androgen receptor-dependent
HIF2α/VEGF signaling pathway. Cancer Res. 74:4420–4430. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kannan S, Sutphin RM, Hall MG, Golfman LS,
Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, et
al: Notch activation inhibits AML growth and survival: A potential
therapeutic approach. J Exp Med. 210:321–337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanno B, Cesi V, Vitali R, Sesti F,
Giuffrida ML, Mancini C, Calabretta B and Raschellà G: Silencing of
endogenous IGFBP-5 by micro RNA interference affects proliferation,
apoptosis and differentiation of neuroblastoma cells. Cell Death
Differ. 12:213–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sutton A, Friand V, Brulé-Donneger S,
Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer
M, Vassy J, et al: Stromal cell-derived factor-1/chemokine (C-X-C
motif) ligand 12 stimulates human hepatoma cell growth, migration,
and invasion. Mol Cancer Res. 5:21–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gaborit N, Abdul-Hai A, Mancini M, Lindzen
M, Lavi S, Leitner O, Mounier L, Chentouf M, Dunoyer S, Ghosh M, et
al: Examination of HER3 targeting in cancer using monoclonal
antibodies. Proc Natl Acad Sci USA. 112:839–844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kesanakurti D, Chetty C, Dinh DH, Gujrati
M and Rao JS: Role of MMP-2 in the regulation of IL-6/Stat3
survival signaling via interaction with α5β1 integrin in glioma.
Oncogene. 32:327–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pettazzoni P, Viale A, Shah P, Carugo A,
Ying H, Wang H, Genovese G, Seth S, Minelli R, Green T, et al:
Genetic events that limit the efficacy of MEK and RTK inhibitor
therapies in a mouse model of KRAS-driven pancreatic cancer. Cancer
Res. 75:1091–1101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Menouny M, Binoux M and Babajko S: Role of
insulin-like growth factor binding protein-2 and its limited
proteolysis in neuroblastoma cell proliferation: Modulation by
transforming growth factor-beta and retinoic acid. Endocrinology.
138:683–690. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saeki N, Gu J, Yoshida T and Wu X:
Prostate stem cell antigen: A Jekyll and Hyde molecule? Clin Cancer
Res. 16:3533–3538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Northcott PA, Jones DT, Kool M, Robinson
GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P,
Taylor MD and Pfister SM: Medulloblastomics: The end of the
beginning. Nat Rev Cancer. 12:818–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sánchez-García I and Grütz G: Tumorigenic
activity of the BCR-ABL oncogenes is mediated by BCL2. Proc Natl
Acad Sci USA. 92:5287–5291. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marshall ME, Hinz TK, Kono SA, Singleton
KR, Bichon B, Ware KE, Marek L, Frederick BA, Raben D and Heasley
LE: Fibroblast growth factor receptors are components of autocrine
signaling networks in head and neck squamous cell carcinoma cells.
Clin Cancer Res. 17:5016–5025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schroeder A, Herrmann A, Cherryholmes G,
Kowolik C, Buettner R, Pal S, Yu H, Müller-Newen G and Jove R: Loss
of androgen receptor expression promotes a stem-like cell phenotype
in prostate cancer through STAT3 signaling. Cancer Res.
74:1227–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vaught DB, Stanford JC, Young C, Hicks DJ,
Wheeler F, Rinehart C, Sánchez V, Koland J, Muller WJ, Arteaga CL
and Cook RS: HER3 is required for HER2-induced preneoplastic
changes to the breast epithelium and tumor formation. Cancer Res.
72:2672–2682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Veronese A, Lupini L, Consiglio J, Visone
R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri
L, et al: Oncogenic role of miR-483-3p at the IGF2/483 locus.
Cancer Res. 70:3140–3149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Butt AJ, Dickson KA, McDougall F and
Baxter RC: Insulin-like growth factor-binding protein-5 inhibits
the growth of human breast cancer cells in vitro and in vivo. J
Biol Chem. 278:29676–29685. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chapman EJ, Kelly G and Knowles MA: Genes
involved in differentiation, stem cell renewal, and tumorigenesis
are modulated in telomerase-immortalized human urothelial cells.
Mol Cancer Res. 6:1154–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kunisada M, Yogianti F, Sakumi K, Ono R,
Nakabeppu Y and Nishigori C: Increased expression of versican in
the inflammatory response to UVB- and reactive oxygen
species-induced skin tumorigenesis. Am J Pathol. 179:3056–3065.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tofighi R, Joseph B, Xia S, Xu ZQ,
Hamberger B, Hökfelt T and Ceccatelli S: Galanin decreases
proliferation of PC12 cells and induces apoptosis via its subtype 2
receptor (GalR2). Proc Natl Acad Sci USA. 105:2717–2722. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin Y, Fukuchi J, Hiipakka RA, Kokontis JM
and Xiang J: Up-regulation of Bcl-2 is required for the progression
of prostate cancer cells from an androgen-dependent to an
androgen-independent growth stage. Cell Res. 17:531–536. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Linnerth NM, Baldwin M, Campbell C, Brown
M, McGowan H and Moorehead RA: IGF-II induces CREB phosphorylation
and cell survival in human lung cancer cells. Oncogene.
24:7310–7319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kashyap AS, Hollier BG, Manton KJ,
Satyamoorthy K, Leavesley DI and Upton Z: Insulin-like growth
factor-I:vitronectin complex-induced changes in gene expression
effect breast cell survival and migration. Endocrinology.
152:1388–1401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin L, Jin Y and Hu K: Tissue-type
plasminogen activator (tPA) promotes M1 macrophage survival through
p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein
kinase (MAPK) pathway. J Biol Chem. 290:7910–7917. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Osborne JK, Larsen JE, Shields MD,
Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L,
Minna JD and Cobb MH: NeuroD1 regulates survival and migration of
neuroendocrine lung carcinomas via signaling molecules TrkB and
NCAM. Proc Natl Acad Sci USA. 110:6524–6529. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sheikpranbabu S, Haribalaganesh R and
Gurunathan S: Pigment epithelium-derived factor inhibits advanced
glycation end-products-induced cytotoxicity in retinal pericytes.
Diabetes Metab. 37:505–511. 2011.PubMed/NCBI
|
|
50
|
Sun J, Pedersen M and Rönnstrand L: The
D816V mutation of c-Kit circumvents a requirement for Src family
kinases in c-Kit signal transduction. J Biol Chem. 284:11039–11047.
2009. View Article : Google Scholar : PubMed/NCBI
|
